An in-depth investigation of ADAM9 protein or mRNA levels in human subjects with APP-related disorders, such as Alzheimer’s disease and autism spectrum disorder, has yet to be performed. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.